Globus Medical, Inc.
GMED · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $11 | $6 | $7 | $7 |
| - Cash | $1 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $0 | $0 |
| Enterprise Value | $11 | $6 | $7 | $7 |
| Revenue | $3 | $2 | $1 | $1 |
| % Growth | 60.6% | 53.3% | 6.8% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 58.9% | 65.1% | 74.2% | 75% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 18.8% | 22.1% | 29.8% | 27.6% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 4.1% | 7.8% | 18.6% | 15.6% |
| EPS Diluted | 0.75 | 1.07 | 1.85 | 1.44 |
| % Growth | -29.9% | -42.2% | 28.5% | – |
| Operating Cash Flow | $1 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |